ABSTRACT NUMBER: ESOC2026A2399 OUTCOMES OF TREATMENT DISCONTINUATION IN NON-VALVULAR ATRIAL FIBRILLATION: A NATIONWIDE REGISTRY STUDY
Hayder Kadhim, Sara Själander, Vilhelm Sjögren, Fredrik Björck, Anders Själander · 2026
Read ABSTRACT NUMBER: ESOC2026A2399 OUTCOMES OF TREATMENT DISCONTINUATION IN NON-VALVULAR ATRIAL FIBRILLATION: A NATIONWIDE REGISTRY STUDY by Hayder Kadhim, Sara Själander, Vilhelm Sjögren, Fredrik Björck, Anders Själander (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13147098.txt.
Description
Hayder Kadhim and co-authors study what happens when heart patients stop blood thinners in a 2026 conference abstract summary. The patients had atrial fibrillation, a shaky heart rhythm that raises stroke risk. Direct oral thinners are the first-line guard. Since no routine lab check tracks their use, staying on them matters. The Swedish study linked three national registries to follow care.
The group held 68,277 patients with an average age near 75. One drug, apixaban, saw the best staying rate at 91.8 percent, while warfarin saw the most stopping. Death rates ran far higher in those who stopped than in those who stayed on care. Risk peaked in the first 28 days after a stop, most of all after a bad event just before.
Catalog record
| CREATOR | Hayder Kadhim, Sara Själander, Vilhelm Sjögren, Fredrik Björck, Anders Själander |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |